Figure 2

MLL-specific and Phenotype-specific signatures. Unsupervised hierarchical clustering performed on 140 samples using (A) translocation-specific (379 probe sets) and (B) phenotype-specific (622 probe sets) signatures. Cluster A clearly separates patients with MLL (orange and blue labels) from patients without MLL translocation (green and red labels). Cluster B distinguishes samples with AML (orange and green labels) from samples with ALL (blue and red labels).